indonesia
overview
RePORT Indonesia is part of the ongoing government-to-government partnership between the National Institutes of Allergy and Infectious Diseases (NIAID), and Indonesia National Institute of Health Research and Development (NIHRD), Ministry of Health (MOH), Indonesia. Indonesia is collaborating with RePORT International through the Indonesia Research Partnership on Infectious Disease (INA-RESPOND) project, funded by the U.S. NIH/NIAID and the Indonesia MOH/NIHRD. This existing partnership between the two governments supports a network of nine academic and research institutions and hospitals to conduct research on infectious diseases and is currently conducting research on febrile illness in Indonesia. The Indonesian MOH has identified TB as a national priority disease area.
Focus
The Indonesia network has enrolled 90 subjects in seven MDR-TB referral Hospitals. Like RePORT Brazil, the parent study has been harmonized with the RePORT International Common Protocol for collecting data and biospecimens using standardized methods and agreed upon time points. Drug susceptible and multi-drug resistant (MDR) patients followed from commencement to end of treatment for drug sensitive patients and two years for MDR patients.
1
INA Respond
2
H. Adam Malik Hospital
3
Persahabatan Hospital
4
Dr. Kariadi Hospital
5
Dr. Sardjito Hospital
6
Dr. Soetomo Hospital
7
Sanglah Hospital
8
Dr. Wahidin Sudirohusodo Hospital
administration
Retna Mustika Indah
INA Respond
Indonesia Research Partnership on Infectious Diseases
Muhammad Karyana
nihrd
National Institute of Health Research and Development, Ministry of Health Republic of Indonesia
Herman Kosasih
INA RESPOND
Indonesia Research Partnership on Infectious Diseases, Jakarta
funding
Indonesia is collaborating with RePORT International through the Indonesia Research Partnership on Infectious Disease (INA-RESPOND) project, funded by the U.S. NIH/NIAID and the Indonesia MOH/NIHRD.